Activation of the receptor protein tyrosine kinase EphB4 in endometrial hyperplasia and endometrial carcinoma

被引:47
作者
Berclaz, G
Karamitopoulou, E
Mazzucchelli, L
Rohrbach, V
Dreher, E
Ziemiecki, A
Andres, AC
机构
[1] Univ Hosp, Dept Obstet & Gynecol, Bern, Switzerland
[2] Univ Bern, Dept Clin Res, Bern, Switzerland
[3] Univ Bern, Inst Pathol, Bern, Switzerland
关键词
endometrial cancer; immunohistochemistry; tyrosine kinase;
D O I
10.1093/annonc/mdg072
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Members of the Eph family of tyrosine kinases have been implicated in embryonic pattern formation and vascular development; however, little is known about their role in the adult organism. We have observed estrogen-dependent EphB4 expression in the normal breast suggesting its implication in the hormone-controlled homeostasis of this organ. Since the endometrium is a similarly hormone dependent organ and endometrial carcinoma is thought to result from estrogenic stimulation, we have investigated EphB4 expression in normal human endometrium and during its carcinogenesis. Patients and methods: EphB4 expression was analyzed immunohistochemically in 26 normal endometrium specimens, 15 hyperplasias and 102 endometrioid adenocarcinomas and correlated with clinical and prognostic tumor characteristics. Results: In normal endometrial tissue no EphB4 protein was detected. Strikingly, we observed a drastic increase (P <0.0001) in the number of EphB4 protein-expressing glandular epithelial cells in the majority of hyperplasias and carcinomas. Moreover, we found a statistically highly significant positive correlation between EphB4 expression and post-menopausal stage of the patient (P = 0.007). Conclusions: These findings indicate that in the endometrium, EphB4 is an early indicator of malignant development and, thus, EphB4 may represent a potent tool for diagnosis and therapeutic intervention.
引用
收藏
页码:220 / 226
页数:7
相关论文
共 30 条
  • [1] ANDRES AC, 1994, ONCOGENE, V9, P1461
  • [2] PROTEIN-TYROSINE KINASE EXPRESSION DURING THE ESTROUS-CYCLE AND CARCINOGENESIS OF THE MAMMARY-GLAND
    ANDRES, AC
    ZUERCHER, G
    DJONOV, V
    FLUECK, M
    ZIEMIECKI, A
    [J]. INTERNATIONAL JOURNAL OF CANCER, 1995, 63 (02) : 288 - 296
  • [3] Apoptosis in the estrous and menstrual cycles
    Andres, AC
    Strange, R
    [J]. JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA, 1999, 4 (02) : 221 - 228
  • [4] Announcements, 1989, Gynecologic Oncology, V35, P125, DOI [DOI 10.1016/0090-8258(89)90027-9, 10.1016/0090-8258(89)90027-9]
  • [5] [Anonymous], 1997, Cell, V90, P403
  • [6] Expression of the receptor protein tyrosine kinase myk-1/htk in normal and malignant mammary epithelium
    Berclaz, G
    Andres, AC
    Albrecht, D
    Dreher, E
    Ziemiecki, A
    Gusterson, BA
    Crompton, MR
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1996, 226 (03) : 869 - 875
  • [7] Berclaz G, 2002, ONCOL REP, V9, P985
  • [8] Lymphadenectomy in high risk endometrial carcinoma stage I and II:: no more morbidity and no need for external pelvic radiation
    Berclaz, G
    Hänggi, W
    Kratzer-Berger, A
    Altermatt, HJ
    Greiner, RH
    Dreher, E
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 1999, 9 (04) : 322 - 328
  • [9] Tyrosine phosphorylation of transmembrane ligands for Eph receptors
    Bruckner, K
    Pasquale, EB
    Klein, R
    [J]. SCIENCE, 1997, 275 (5306) : 1640 - 1643
  • [10] LIGANDS FOR EPH-RELATED RECEPTOR TYROSINE KINASES THAT REQUIRE MEMBRANE ATTACHMENT OR CLUSTERING FOR ACTIVITY
    DAVIS, S
    GALE, NW
    ALDRICH, TH
    MAISONPIERRE, PC
    LHOTAK, V
    PAWSON, T
    GOLDFARB, M
    YANCOPOULOS, GD
    [J]. SCIENCE, 1994, 266 (5186) : 816 - 819